A practical guide for providers on helping patients locate Leuprolide during the ongoing shortage, including distributor strategies and alternative therapies.
You've written the prescription. The prior authorization went through. Your patient is scheduled for their injection. And then you get the call: your distributor can't fill the order, or the patient's pharmacy doesn't have it.
This scenario has become all too common since 2020, when the Leuprolide (Lupron Depot) shortage first appeared on the ASHP drug shortage list. Six years later, intermittent supply disruptions continue to affect practices across urology, oncology, gynecology, and pediatric endocrinology.
This guide provides actionable steps your practice can take to minimize the impact on patient care.
As of early 2026, here's where Leuprolide supply stands:
Understanding the supply dynamics can help you communicate with frustrated patients and make better sourcing decisions:
Don't rely on a single distributor. Establish accounts with multiple specialty distributors to increase your chances of securing inventory:
Each distributor may receive different allocations at different times. Having multiple accounts gives you more chances to locate available stock.
Don't wait until the patient is in the chair to order. Build a 2-4 week lead time into your ordering process. If you know a patient's next injection date, place the order as early as your distributor allows. During allocation periods, ordering early in the cycle (Monday/Tuesday) tends to be more successful.
Medfinder for Providers tracks real-time pharmacy availability for Leuprolide and related medications. If your practice can't source the drug directly, you can use Medfinder to identify nearby pharmacies or specialty pharmacies that have it in stock, and coordinate with the patient accordingly.
Having a pre-established protocol for when Lupron Depot is unavailable can save critical time. Here's a framework by indication:
Advanced Prostate Cancer:
Endometriosis:
Uterine Fibroids:
Central Precocious Puberty:
For patients who are stable on Leuprolide but at risk of supply disruption, consider proactively obtaining prior authorization for a backup medication. Document the shortage as the clinical rationale. This way, if Lupron Depot becomes unavailable, you can switch without treatment delay.
For a comprehensive review of all Leuprolide alternatives with clinical details, see our alternatives guide. For the provider-specific shortage analysis, see our prescriber shortage briefing.
The Leuprolide shortage is a systemic challenge that requires systemic solutions — but in the meantime, individual practices can make a meaningful difference by planning ahead, diversifying sources, and maintaining flexibility in their prescribing approach.
Visit medfinder.com/providers for provider-specific tools and resources to support your patients through this shortage and beyond.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
